(Q46779228)

25 December 2017

title

Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation (English)

1 reference

25 December 2017

idiopathic pulmonary fibrosis

1 reference

1 reference

based on heuristic

inferred from title

author

Sabina Antonela Antoniu

series ordinal

1

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

25 December 2017

Expert Opinion on Investigational Drugs

published in

1 reference

25 December 2017

volume

14

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

page(s)

1443-1447

1 reference

25 December 2017

Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1443

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1443

Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1443

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1443

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1443

Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1443

A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1443

10.1517/13543784.14.11.1443

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16255682

1 reference

25 December 2017